🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
MorphoSys Research Site
Start Date
2021-05-11
Trial ID
NCT04824092
This study is a phase III, randomized, open-label, international, multicent...
Status
Recruiting
Location
Krankenhaus der Barmherzigen Brüder Graz - Abteilung Für Innere Medizin I
Start Date
2024-06-07
Trial ID
NCT06284122
The purpose of this study is to compare the efficacy and safety of genotype...
Status
Recruiting
Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Start Date
2025-04-01
Trial ID
NCT06803693
A multicenter, prospective, randomized, open-label, controlled trial to eva...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2022-06-01
Trial ID
NCT05351346
Treatments Being Tested
This trial will compare tisagenlecleucel to standard of care in adult parti...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-10-02
Trial ID
NCT05888493
Treatments Being Tested
This study aims to compare the efficacy and safety of Polatuzumab Vedotin, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06516978
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2008-02
Trial ID
NCT00602836
Treatments Being Tested
This is an open-label, multicenter study to evaluate safety and tolerabilit...
Status
Active Not Recruiting
Location
Aichi Cancer Center Hospital
Start Date
2020-12-15
Trial ID
NCT04661007
Treatments Being Tested